Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kolios

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
World Journal of Pediatrics : WJP|May 31, 2018
Are therapeutic diets an emerging additional choice in autism spectrum disorder management?M Gogou, G Kolios
Psychiatrike = Psychiatriki|June 17, 2020
[Is there place for nutrition in the treatment of children with autism spectrum disorder?]M Gogou, G Kolios
Hepato-Gastroenterology|December 5, 1998
Mediators of inflammation: production and implication in inflammatory bowel diseaseG Kolios, C Petoumenos, A Nakos
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 30, 2008
[CIRS in surgery]E Domínguez-Fernández, G Kolios, M Rothmund
Clinical Chemistry and Laboratory Medicine|October 17, 2001
Routine differential diagnosis of proteinurias by capillary electrophoresisG Kolios, E Bairaktari, O Tsolas, et al.
The Journal of Biological Chemistry|June 8, 1999
Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanismK Wright, G Kolios, J Westwick, et al.
Biotechnology and Applied Biochemistry|December 1, 1991
Immunological versatility and carbon regulation of Cellulomonas fimi endo-1,4-beta-glucanasesG Kolios, G K Papadopoulos, I Roussis, et al.
The Journal of Biological Chemistry|May 9, 1997
Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29K Wright, S G Ward, G Kolios, et al.
Pulmonology|January 3, 2021
Influence of inhalation device, active substance, and drug formulation on the compliance of patients with obstructive pulmonary diseases. A physicians... perspectiveS G Theodorakis, G Kolios, V Tzilas, et al.
Scientific Reports|October 5, 2017
Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite scoreE Karatzas, M M Bourdakou, G Kolios, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
World Journal of Pediatrics : WJP|May 31, 2018
Are therapeutic diets an emerging additional choice in autism spectrum disorder management?M Gogou, G Kolios
Psychiatrike = Psychiatriki|June 17, 2020
[Is there place for nutrition in the treatment of children with autism spectrum disorder?]M Gogou, G Kolios
Hepato-Gastroenterology|December 5, 1998
Mediators of inflammation: production and implication in inflammatory bowel diseaseG Kolios, C Petoumenos, A Nakos
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 30, 2008
[CIRS in surgery]E Domínguez-Fernández, G Kolios, M Rothmund
Clinical Chemistry and Laboratory Medicine|October 17, 2001
Routine differential diagnosis of proteinurias by capillary electrophoresisG Kolios, E Bairaktari, O Tsolas, et al.
The Journal of Biological Chemistry|June 8, 1999
Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanismK Wright, G Kolios, J Westwick, et al.
Biotechnology and Applied Biochemistry|December 1, 1991
Immunological versatility and carbon regulation of Cellulomonas fimi endo-1,4-beta-glucanasesG Kolios, G K Papadopoulos, I Roussis, et al.
The Journal of Biological Chemistry|May 9, 1997
Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29K Wright, S G Ward, G Kolios, et al.
Pulmonology|January 3, 2021
Influence of inhalation device, active substance, and drug formulation on the compliance of patients with obstructive pulmonary diseases. A physicians... perspectiveS G Theodorakis, G Kolios, V Tzilas, et al.
Scientific Reports|October 5, 2017
Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite scoreE Karatzas, M M Bourdakou, G Kolios, et al.
Pageof 5